Clinical trial
Effect of Inhaled Budesonide on the Incidence and Severity of Acute Mountain Sickness at 4559 m
NCT02811016 is registered in ClinicalTrials.gov with Salzburger Landeskliniken as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Inhaled Budesonide on the Incidence and Severity of Acute Mountain Sickness at 4559 m
- Lead sponsor
- Salzburger Landeskliniken
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 30, 2016
- Completion date
- October 31, 2016
- Enrollment
- 51 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute mountain sickness